Gastroenterology
Volume 142, Issue 1 , Pages 8-11 , January 2012

Lipids in Liver Disease: Looking Beyond Steatosis

  • Robert F. Schwabe

      Affiliations

    • Corresponding Author InformationReprint requests Address requests for reprints to: Robert F. Schwabe, MD, Russ Berrie Pavilion, Room 415, Columbia University, 1150 St. Nicholas Avenue, New York, New York 10032

  • Image Result

    Increased HSC activation by dietary cholesterol. Increased dietary cholesterol up-regulates TLR4 protein levels in HSCs, which in turn down-regulates the inhibitory TGF-β pseudoreceptor Bambi. The res

    Increased HSC activation by dietary cholesterol. Increased dietary cholesterol up-regulates TLR4 protein levels in HSCs, which in turn down-regulates the inhibitory TGF-β pseudoreceptor Bambi. The resulting increase in TGF-β signaling promotes increased HSC activation and liver fibrosis.

  • Image Result
    Hydrolysis of triglyceride in hepatic lipid droplets yields toxic fatty acids, which can activate an injurious positive feedback loop by activating PPAR-α and stimulating triglyceride lipase(s). NorUD

    Hydrolysis of triglyceride in hepatic lipid droplets yields toxic fatty acids, which can activate an injurious positive feedback loop by activating PPAR-α and stimulating triglyceride lipase(s). NorUDCA, PPAR-α inhibition, and high-fat feeding can each interrupt the cycle by preventing further hydrolysis and shifting equilibrium in the hepatocyte toward triglyceride synthesis and storage.

 Conflicts of interest The authors disclose no conflicts.

PII: S0016-5085(11)01565-4

doi: 10.1053/j.gastro.2011.11.004

Gastroenterology
Volume 142, Issue 1 , Pages 8-11 , January 2012